These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1777652)

  • 21. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.
    Saito M; Eto M; Kaku K
    Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein H levels in diabetic subjects: correlation with cholesterol levels.
    Cassader M; Ruiu G; Gambino R; Veglia F; Pagano G
    Metabolism; 1997 May; 46(5):522-5. PubMed ID: 9160818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.
    Joven J; Vilella E; Costa B; Turner PR; Richart C; Masana L
    Clin Chem; 1989 May; 35(5):813-6. PubMed ID: 2720975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
    Bakris GL; Smith AC; Richardson DJ; Hung E; Preston R; Goldberg R; Epstein M
    J Hum Hypertens; 2002 Mar; 16(3):185-91. PubMed ID: 11896508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
    Wägner AM; Pérez A; Calvo F; Bonet R; Castellví A; Ordóñez J
    Diabetes Care; 1999 May; 22(5):812-7. PubMed ID: 10332687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
    Ribault A; Durou MR; Letellier C; Wojcik F; Poirier JY; Ruelland A
    Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein C subtype distribution in type 2 diabetes mellitus.
    Gomez JA; del Pozo C; Sorribas A; Serrat J; Gonzalez-Sastre F; de Leiva A
    Diabet Med; 1989 Mar; 6(2):127-30. PubMed ID: 2522853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein (a) levels and phenotypes in NIDDM patients with microalbuminuria and albuminuria.
    Lam KS; Pang RW; Wat MS; Lauder IJ; Janus ED
    Nephrol Dial Transplant; 1996 Nov; 11(11):2229-36. PubMed ID: 8941583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria.
    Watts GF; Naumova R; Slavin BM; Morris RW; Houlston R; Kubal C; Shaw KM
    Diabet Med; 1989; 6(1):25-30. PubMed ID: 2522370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy.
    Gall MA; Rossing P; Hommel E; Voldsgaard AI; Andersen P; Nielsen FS; Dyerberg J; Parving HH
    Scand J Clin Lab Invest; 1992 Oct; 52(6):513-21. PubMed ID: 1411263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
    Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
    Katoh K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.
    Császár A; Dieplinger H; Sandholzer C; Karádi I; Juhász E; Drexel H; Halmos T; Romics L; Patsch JR; Utermann G
    Diabetologia; 1993 Jan; 36(1):47-51. PubMed ID: 8436252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
    Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
    Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
    Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patients.
    Buscaglia P; Gazzaruso C; Garzaniti A; Bonetti G; Fratino P; Geroldi D
    Diabetes Care; 1995 Aug; 18(8):1202-3. PubMed ID: 7587865
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus.
    Duman BS; Oztürk M; Yilmazer S; Cağatay P; Hatemi H
    Cell Biochem Funct; 2006; 24(3):261-7. PubMed ID: 16634094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.